Clinical trial
A Phase IV 48 Week, Open Label, Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
NCT01045369 is registered in ClinicalTrials.gov with Therapeutic Concepts as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV 48 Week, Open Label, Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
- Lead sponsor
- Therapeutic Concepts
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- June 30, 2011
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.